RAS AL KHAIMAH / GULF TIME Following its strategic collaboration agreement with Marriott International, ATARA …
Read More »Novartis targets breast cancer drug approval to take on Pfizer
Bloomberg An experimental Novartis AG treatment for a form of advanced breast cancer slashed the risks of death and the disease progressing in a study, paving way for the Swiss drugmaker to seek regulatory approval in the U.S. and Europe by the end of the year. Novartis expects to win the first approval for the drug, ribociclib, by the …
Read More »
The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.













